Literature DB >> 9380696

Lack of cell cycle regulation of telomerase activity in human cells.

S E Holt1, D L Aisner, J W Shay, W E Wright.   

Abstract

Conflicting reports have appeared concerning the cell cycle regulation of telomerase activity and its possible repression during quiescence and cell differentiation. We have reexamined these issues in an attempt to uncover the basis for the discrepancies. Variations in extracted telomerase activity during the cell cycle are not observed in cells sorted on the basis of DNA content. Variations are observed in cells synchronized using some biochemical cell cycle inhibitors, but only with those agents where cellular toxicity is evident. A progressive decline in telomerase activity is observed in cells whose growth rate is reduced from seven to eight population doublings per week to one to two doublings per week. Telomerase is largely absent in cells that truly exit the cell cycle and do not divide over the 7-day period. Although it is not necessary for all cell types to regulate telomerase in the same way, we conclude that in the immortal cultured cell lines examined, extracted telomerase activity does not change significantly during progression through the stages of the cell cycle. Telomerase activity generally correlates with growth rate and is repressed in cells that exit the cell cycle and become quiescent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9380696      PMCID: PMC23449          DOI: 10.1073/pnas.94.20.10687

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Telomerase activity in human germline and embryonic tissues and cells.

Authors:  W E Wright; M A Piatyszek; W E Rainey; W Byrd; J W Shay
Journal:  Dev Genet       Date:  1996

2.  Telomerase activity in normal human endothelial cells.

Authors:  R Hsiao; H W Sharma; S Ramakrishnan; E Keith; R Narayanan
Journal:  Anticancer Res       Date:  1997 Mar-Apr       Impact factor: 2.480

3.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

Review 4.  Telomerase activity in human cancer.

Authors:  J W Shay; W E Wright
Journal:  Curr Opin Oncol       Date:  1996-01       Impact factor: 3.645

5.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

6.  A role for both RB and p53 in the regulation of human cellular senescence.

Authors:  J W Shay; O M Pereira-Smith; W E Wright
Journal:  Exp Cell Res       Date:  1991-09       Impact factor: 3.905

7.  Telomere length predicts replicative capacity of human fibroblasts.

Authors:  R C Allsopp; H Vaziri; C Patterson; S Goldstein; E V Younglai; A B Futcher; C W Greider; C B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.

Authors:  J Albanell; W Han; B Mellado; R Gunawardane; H I Scher; E Dmitrovsky; M A Moore
Journal:  Cancer Res       Date:  1996-04-01       Impact factor: 12.701

9.  Telomerase activity in normal and neoplastic breast.

Authors:  J l Tsao; Y Zhao; J Lukas; X Yang; A Shah; M Press; D Shibata
Journal:  Clin Cancer Res       Date:  1997-04       Impact factor: 12.531

10.  Immortalization of human mammary epithelial cells transfected with mutant p53 (273his).

Authors:  L S Gollahon; J W Shay
Journal:  Oncogene       Date:  1996-02-15       Impact factor: 9.867

View more
  38 in total

1.  Functional requirement of p23 and Hsp90 in telomerase complexes.

Authors:  S E Holt; D L Aisner; J Baur; V M Tesmer; M Dy; M Ouellette; J B Trager; G B Morin; D O Toft; J W Shay; W E Wright; M A White
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

Review 2.  Complex regulation of telomerase activity: implications for cancer therapy.

Authors:  K S Elenitoba-Johnson
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

3.  Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide.

Authors:  T J Moriarty; S Dupuis; C Autexier
Journal:  Leukemia       Date:  2002-06       Impact factor: 11.528

4.  Growth inhibition of human glioma cells by transfection-induced P21 and its effects on telomerase activity.

Authors:  K Harada; K Kurisu; T Sadatomo; H Tahara; E Tahara; T Ide; E Tahara
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

5.  Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment.

Authors:  Victoria L Bae-Jump; Chunxiao Zhou; John F Boggess; Young E Whang; Lisa Barroilhet; Paola A Gehrig
Journal:  Gynecol Oncol       Date:  2010-09-21       Impact factor: 5.482

6.  Cell cycle-regulated trafficking of human telomerase to telomeres.

Authors:  Rebecca L Tomlinson; Tania D Ziegler; Teerawit Supakorndej; Rebecca M Terns; Michael P Terns
Journal:  Mol Biol Cell       Date:  2005-12-07       Impact factor: 4.138

Review 7.  Telomere length homeostasis.

Authors:  Nele Hug; Joachim Lingner
Journal:  Chromosoma       Date:  2006-06-02       Impact factor: 4.316

8.  Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues.

Authors:  E Hiyama; K Hiyama; T Yokoyama; J W Shay
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

9.  Effects of allicin on both telomerase activity and apoptosis in gastric cancer SGC-7901 cells.

Authors:  Li Sun; Xu Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 10.  Human telomerase and its regulation.

Authors:  Yu-Sheng Cong; Woodring E Wright; Jerry W Shay
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.